This Time the Numbers Show We Can’t Be Too Careful. Cass Sunstein, March 26, 2020, Opinion, "I have long been an enthusiastic defender of quantitative cost-benefit analysis, and recently wrote a book about it.  I have also long been a critic of the precautionary principle, which calls for potentially expensive precautions against bad outcomes in the face of scientific uncertainty.  In the context of the coronavirus pandemic, it’s unusually challenging to engage in quantitative cost-benefit..." Link